4-Cl-PVP Research Chemical Powder Europe
4-Cl-PVP (4-Chloro-α-pyrrolidinopentiophenone) is a synthetic stimulant from the cathinone and pyrrolidine classes, known for its strong dopaminergic activity and structural similarity to α-PVP. This compound is intended strictly for forensic, analytical, and scientific research. It has gained popularity in academic and chemical study labs due to its high potency and well-defined structure.
What is 4-Cl-PVP?
4-Cl-PVP is a derivative of α-PVP, modified by the addition of a chlorine atom at the 4-position of the phenyl ring. This small change increases its receptor binding affinity, making it an important compound in neurochemical and pharmacological research. It is widely used in controlled lab environments to study its stimulant and behavioral effects.
Key Features:
-
CAS Number: Not officially registered
-
IUPAC Name: 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one
-
Chemical Formula: C15H20ClNO
-
Molar Mass: 265.78 g/mol
-
Appearance: Off-white or light beige crystalline powder
-
Purity: ≥98% (HPLC tested)
-
Storage: Store in a cool, dry, and dark place
-
Shelf Life: 24 months when sealed and stored properly
Benefits:
-
Valuable for studying stimulant compound analogs
-
Useful in understanding chlorinated phenyl ring modifications
-
Employed in metabolism and toxicology profiling
-
Aids in receptor affinity mapping and SAR analysis
Intended Uses (Research Only):
-
In-vitro receptor binding studies
-
Comparative stimulant effect studies
-
LC/MS and GC/MS analytical testing
-
Molecular docking and simulation research
Side Effects (Observed in Research Contexts):
-
Stimulant-induced anxiety
-
Increased heart rate and locomotion
-
Temporary euphoria in animal models
-
Reduced appetite and sleep cycle alteration
Note: For laboratory research use only. Not for human or veterinary use.
Recommended Research Doses:
-
Microgram-to-milligram range (5mg to 30mg) depending on test subject and study type
-
Handle with extreme caution due to potent activity



Reviews
There are no reviews yet.